Key result
Top-quartile hospital home time linked to ~41% lower post-TAVR 30-day mortality.
Why the study?
Patient-centric measures of hospital performance for transcatheter aortic valve replacement (TAVR) are needed.
Does 30-day risk-adjusted home time serve as a valid hospital-level performance metric for patients undergoing TAVR?
Observational (n=160,792)
Yes
Does 30-day risk-adjusted home time serve as a valid hospital-level performance metric for patients undergoing TAVR?
Risk-adjusted 30-day home time is a novel, patient-centered hospital performance metric for TAVR that correlates well with traditional clinical outcomes and provides complementary assessment of care quality.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Some hospitals that have had lower readmission rates were actually having high mortality rates. If you die, you're not going to be readmitted.”
Higher 30-day home time was associated with lower TAVR mortality; leaves open its added value for hospital performance ranking.
Background: Patient-centric measures of hospital performance for transcatheter aortic valve replacement (TAVR) are needed. Objectives: Evaluate 30-day risk-adjusted home time as a hospital performance metric for patients undergoing TAVR. Methods: We identified 160,792 Medicare beneficiaries who underwent elective TAVR from 2015 to 2019. Home time was calculated for each patient as the number of days alive and spent outside a hospital, skilled nursing (SNF), and long-term acute care facilities for 30 days after the TAVR procedure date. Correlations between risk-adjusted 30-day home time and other metrics (30-day risk-adjusted readmission rate (RSRR), 30-day risk-adjusted mortality rate (RSMR), and annual TAVR volume) were estimated using Pearson correlation. Meaningful upward or downward reclassification (≥2 quartile rank) in hospital performance based on quartiles of risk-adjusted 30-day home time compared with quartiles of other measures were assessed. Results: Median risk-adjusted 30-day home time was 27.5 days (IQR:26.3–28.5). The largest proportion of days lost from 30-day home time was hospital stay after TAVR and SNF stay. An inverse correlation was observed between hospital-level risk-adjusted 30-day home time and 30-RSRR (r:−0.465, P<0.001) 30-RSMR (r:−0.399, P<0.001). The use of the 30-day risk-adjusted home time was associated with reclassification in the hospital performance rank hospitals compared with other metrics (9.1% up-classified; 11.2% down-classified vs. RSRR; 9.1% up-classified; 10.3% down-classified vs. RSMR, and 0.394 vs. annual TAVR volume, 20.1% up-classified; 19.3% down-classified vs. TAVR volume). Conclusion: Risk-adjusted 30-day home time represents a novel patient-centered performance metric for TAVR hospitals that may provide a complimentary assessment to currently used metrics.
No takes yet. Share an insight, caveat, or question.
Mentias et al. (2022) conducted an observational in Aortic stenosis (n=160,792). High hospital-level risk-adjusted 30-day home time (Quartile 4) vs. Low hospital-level risk-adjusted 30-day home time (Quartile 1) was evaluated on 30-day mortality (p=<0.01). Patients treated at hospitals in the highest quartile of risk-adjusted 30-day home time had lower 30-day mortality compared to those in the lowest quartile.
Synapse has enriched 10 related papers. Consider them for comparative context: